lug
8
Dott. Luigi Vicari on luglio 8th, 2009
The EU Committee for Medicinal Products for Human Use (CHMP) has recently considered the available evidence for an interaction between clopidogrel and proton pump inhibitors (PPIs). They concluded that PPIs reduce the effectiveness of clopidogrel in preventing the recurrence of adverse cardiac events such as heart attack and coronary artery restenosis (renarrowing of the artery [...]
Continue reading about Interactions between the use of clopidogrel and proton pump inhibitors
Disponibile un prontuario farmaceutico aggiornato al 26/02/2009. Prontuario Farmaci del SSN aggiornato al 26-02-2009
Fentanyl
